Rana McKay: The perioperative use of ctDNA in localized prostate cancer
Rana McKay, Associate Professor of Medicine at UC San Diego, shared a post on X about her recent paper published in Bladder Cancer:
“The perioperative use of ctDNA has the potential to transform our approach in localized prostate cancer. This elegant review led by Tyler Stewart highlights the nuts and bolts.”
“Perioperative Use of ctDNA to Guide Treatment for Urothelial Carcinoma: The Future is Now”
Authors: Tyler Stewart, Healther Chalfin, Nicholas Simon, Alan Tan, Andrea Apolo, Rana McKay.
More posts featuring Rana McKay.
Dr. Rana McKay is a board-certified medical oncologist and specializes in urogenital cancers, offering treatment for bladder, kidney, prostate, and testicular cancer patients. Leading a multi-disciplinary prostate cancer clinic at UC San Diego, she ensures comprehensive care through collaboration with urologists and radiation oncologists.
As an associate professor, Dr. McKay mentors students and conducts research on clinical trials and novel biomarkers for genitourinary malignancies. Dr. McKay is a member of the American Society of Clinical Oncology and the American Association for Cancer Research.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023